Ezra Baraban

1.3k total citations
69 papers, 633 citations indexed

About

Ezra Baraban is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Ezra Baraban has authored 69 papers receiving a total of 633 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pulmonary and Respiratory Medicine, 25 papers in Surgery and 19 papers in Molecular Biology. Recurrent topics in Ezra Baraban's work include Renal cell carcinoma treatment (19 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Renal and related cancers (11 papers). Ezra Baraban is often cited by papers focused on Renal cell carcinoma treatment (19 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Renal and related cancers (11 papers). Ezra Baraban collaborates with scholars based in United States, Canada and Germany. Ezra Baraban's co-authors include Anupma Nayak, Kumarasen Cooper, Virginia A. LiVolsi, Daniel Lubin, Paul J. Zhang, Adam Bagg, Andrea Watters, Zachary T. Schug, Meenhard Herlyn and Andrew J. Phillips and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ezra Baraban

55 papers receiving 626 citations

Peers

Ezra Baraban
Ryoko Saito Japan
Anne Lise Ferrara Italy
Samy Hakroush Germany
Carlos E. Irarrázabal Chile
Lin Tang China
Melker Göransson Sweden
Stefan Zöllner Germany
Jonas Feilchenfeldt Switzerland
Hai Zhou China
Bhoom Suktitipat Thailand
Ryoko Saito Japan
Ezra Baraban
Citations per year, relative to Ezra Baraban Ezra Baraban (= 1×) peers Ryoko Saito

Countries citing papers authored by Ezra Baraban

Since Specialization
Citations

This map shows the geographic impact of Ezra Baraban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ezra Baraban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ezra Baraban more than expected).

Fields of papers citing papers by Ezra Baraban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ezra Baraban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ezra Baraban. The network helps show where Ezra Baraban may publish in the future.

Co-authorship network of co-authors of Ezra Baraban

This figure shows the co-authorship network connecting the top 25 collaborators of Ezra Baraban. A scholar is included among the top collaborators of Ezra Baraban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ezra Baraban. Ezra Baraban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Lan, Georges Tabet, Charles C. Guo, et al.. (2025). Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis. Human Pathology. 157. 105767–105767. 1 indexed citations
2.
Elias, Roy, Thomas R. Nirschl, Michael E. Rezaee, et al.. (2025). Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic Similarity. Cancer Research Communications. 5(5). 743–755. 1 indexed citations
3.
Ged, Yasser, Luis Contreras, Roy Elias, et al.. (2025). Multi-institutional Analysis of Immune-Oncology Combination Therapy for Metastatic MiT Family Translocation Renal Cell Carcinoma. Journal of Immunotherapy. 48(3). 113–117. 1 indexed citations
4.
Li, Huili, Vamsi Parimi, Burles A. Johnson, et al.. (2025). Clinicopathologic and Prognostic Features of Sarcomatoid Urothelial Carcinoma. The American Journal of Surgical Pathology. 50(1). 51–61.
5.
Baraban, Ezra, et al.. (2025). Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat. npj Precision Oncology. 9(1). 48–48. 2 indexed citations
6.
Rowe, Steven P., Benjamin L. Viglianti, Lilja B. Sólnes, et al.. (2024). Molecular imaging for non-invasive risk stratification of renal masses. Diagnostic and Interventional Imaging. 105(9). 305–310. 3 indexed citations
7.
Deutsch, Julie S., Tricia R. Cottrell, Krista Y. Chen, et al.. (2024). Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Final analysis of a multi-institutional reproducibility study.. Journal of Clinical Oncology. 42(16_suppl). 2515–2515.
8.
Vlachou, Evangelia, Burles A. Johnson, Ezra Baraban, Rosa Nadal, & Jean Hoffman‐Censits. (2024). Current Advances in the Management of Nonurothelial Subtypes of Bladder Cancer. American Society of Clinical Oncology Educational Book. 44(3). e438640–e438640. 4 indexed citations
9.
Baraban, Ezra, et al.. (2024). Perinephric myxoid pseudotumor of fat: A series of 13 cases and literature review. Human Pathology. 154. 105681–105681. 2 indexed citations
10.
Dermawan, Josephine K., Faizan Malik, John Gross, et al.. (2024). Novel PAX3::MAML3 Fusion Identified in Alveolar Rhabdomyosarcoma, Using DNA Methylation Profiling to Expand the Genetic Spectrum of “Fusion-Positive” Cases. Modern Pathology. 37(11). 100594–100594. 1 indexed citations
11.
Ribeiro, Efrain, Laura Morsberger, Rena R. Xian, et al.. (2024). Diagnostic and Prognostic/Therapeutic Significance of Comprehensive Analysis of Bone and Soft Tissue Tumors Using Optical Genome Mapping and Next-Generation Sequencing. Modern Pathology. 38(4). 100684–100684. 6 indexed citations
12.
Fishman, Elliot K., et al.. (2024). Cinematic rendering of primary adrenal lymphoma. Current Problems in Diagnostic Radiology. 53(5). 641–647. 1 indexed citations
13.
Rezaee, Michael E., Maximilian Pallauf, Sean A. Fletcher, et al.. (2024). Prognostic significance of pT3a staging subclassifications in renal cell carcinoma: Not all pT3a are equal. Urologic Oncology Seminars and Original Investigations. 42(4). 119.e23–119.e29. 2 indexed citations
14.
Deutsch, Julie S., Evan J. Lipson, Ludmila Danilova, et al.. (2023). Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinoma. Cell Reports Medicine. 4(2). 100947–100947. 18 indexed citations
15.
Baraban, Ezra & Jonathan I. Epstein. (2022). Prostate Cancer. Surgical pathology clinics. 15(4). 579–589. 6 indexed citations
16.
Avery, Robin K., et al.. (2022). Case Report: New Onset Lymphadenopathy After Immune Checkpoint Inhibitor Therapy Presents a Clinicopathological and Radiological Challenge. Frontiers in Oncology. 12. 876797–876797. 2 indexed citations
17.
Zou, Yongkang, Andrea Watters, Nan Cheng, et al.. (2019). Polyunsaturated Fatty Acids from Astrocytes Activate PPARγ Signaling in Cancer Cells to Promote Brain Metastasis. Cancer Discovery. 9(12). 1720–1735. 117 indexed citations
18.
19.
Herman, Daniel S., et al.. (2019). Falsely Increased Plasma Lactate Dehydrogenase without Hemolysis Following Transport through Pneumatic Tube System. The Journal of Applied Laboratory Medicine. 4(3). 433–438. 8 indexed citations
20.
Sikka, Gautam, Alexandre Benjo, Norimichi Koitabashi, et al.. (2009). Leptin is essential in maintaining normal vascular compliance independent of body weight. International Journal of Obesity. 34(1). 203–206. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryoko Saito Breakdown of academic impact, for papers by Anne Lise Ferrara Breakdown of academic impact, for papers by Samy Hakroush Breakdown of academic impact, for papers by Carlos E. Irarrázabal Breakdown of academic impact, for papers by Lin Tang Breakdown of academic impact, for papers by Melker Göransson Breakdown of academic impact, for papers by Stefan Zöllner Breakdown of academic impact, for papers by Jonas Feilchenfeldt Breakdown of academic impact, for papers by Hai Zhou Breakdown of academic impact, for papers by Bhoom Suktitipat
Rankless by CCL
2026